1. Home
  2. Bills
  3. H.R. 6081

H.R. 6081 · 111th Congress · 2009–2010

Stem Cell Therapeutic and Research Reauthorization Act of 2010

H.R. 6081 in the 111th Congress (2009–2010) was introduced on Aug 9, 2010, sponsored by C. W. Bill Young with 10 co-sponsors.

During the 111th Congress (2009–2010), Barack Obama was president, and Democrats held majorities in both the House and Senate.

Status
Introduced
Introduced
Aug 9, 2010
Co-sponsors
10
Policy area
Health

What it does

Stem Cell Therapeutic and Research Reauthorization Act of 2010 - (Sec. 2) Amends the Stem Cell Therapeutic and Research Act of 2005 to revise provisions related to the National Cord Blood Inventory (the Inventory), including to establish an inventory goal of at least 150,000 new units of cord blood to be made available under the C.W. Bill Young Cell Transplantation Program (the Program).

Summary by the nonpartisan Congressional Research Service.

Sponsor

C. W. Bill Young (R-FL). Co-sponsors: 10 Democrats.

Where it stands

  • IntroducedAug 9, 2010
  • Passed the House—
  • Passed the Senate—
  • Sent to the President—
  • Became law—

Latest action: Placed on the Union Calendar, Calendar No. 383. (Sep 28, 2010)

Other Health bills in the 111th Congress

Committees

More

From GovInfo bill records, Congressional Research Service summaries, Voteview roll calls and lobbying reports.

Cite or embed this page

Capitol Receipts, “H.R. 6081 (111th Congress): Stem Cell Therapeutic and Research…,” https://www.capitolreceipts.com/bill/111-hr-6081/stem-cell-therapeutic-and-research-reauthorization-act-of-2010 (accessed 2026-10-17).

Open the interactive version ›